Andere talen Noxopharm Limited

Aandelen

NOX

AU000000NOX9

Beurs gesloten - Australian S.E. Andere beurzen 06:11:24 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,06 ^AUD	-3,23%		-14,29%	-15,49%

27/02	Noxopharm verkleint fiscaal H1 nettoverlies ondanks lagere belastingvoordelen voor R&D	MT
26/02	Noxopharm Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	04/04
Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	27/02
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Noxopharm Extends Strategic Partnership with Hudson Institute of Medical Research	13/02
Noxopharm Receives AU$6.1 Million R&D tax Rebate; Shares Up 8%	16/11
Noxopharm talks partnership with Hudson Institute of Medical Research	12-10-23
Concerns of Further US Monetary Tightening Push Australian Shares to Nearly 11-Month Low	04-10-23
US FDA Grants Orphan Drug Status to Noxopharm's Pancreatic Cancer Drug; Shares Surge 73%	04-10-23
Noxopharm Validates Efficacy of Cancer Treatment in Animal Study; Shares Rally 13%	28-09-23
Noxopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
NobleOak Life Secures Approval from Financial Services Regulator for Reporting Standards	03-07-23
Noxopharm Limited Announces Change of Registered Office and Principal Place of Business	19-06-23
Study Finds Noxopharm's New SOF-XX Drug Reduces Inflammation	19-05-23
Noxopharm's NOXO Options to Expire June 18; Shares Down 17%	08-05-23
Noxopharm to Discontinue Veyonda Trials; to Focus on Chroma, Sofra Platforms; Shares Plummet 41%	06-04-23
Noxopharm to Develop Vaccine Enhancer; Shares Rise 3%	28-03-23
Noxopharm Limited Announces Novel mRNA Vaccine Enhancer	27-03-23
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24-02-23
Noxopharm Limited to Present Sofra Study at Lupus 2023 Conference	21-02-23
NobleOak Life to Release Shares from Voluntary Escrow	09-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Noxopharm Limited

Aandelen

NOX

AU000000NOX9

Andere talen

Filters